Design of Nanostructured Lipid Carriers Ubiquinone-10 for Transdermal Treatment

Fatchur Rochman, M and Isnaeni, Isnaeni and Hendradi, Esti (2018) Design of Nanostructured Lipid Carriers Ubiquinone-10 for Transdermal Treatment. International Journal of Drug Delivery Technology, 8 (3). pp. 116-120. ISSN 0975 4415

[img] Text (FULLTEXT)
C-7 fix.pdf

Download (4MB)
[img] Text (SIMILARITY)
Result Bukti C-07.pdf

Download (2MB)
[img] Text (PEER REVIEW)
Rev C-7.pdf

Download (1MB)
Official URL:,Vol8,Iss...


Ubiquinone-10 is a cellular endogenous antioxidant that resides in the epidermal layer. Ubiquinone-10 can increase the production of basal membrane components, fibroblast proliferation and protect cells from oxidative damage, so with increasing age, the amount of Ubiquinone-10 body will decrease. Bioavailability and permeability of Ubiquinone-10 are very low, thus affecting the potential efficacy and absorption in Ubiquinone-10. The preparation of Ubiquinone-10 formulation needs to be done to obtain products that have good bioavailability. Nanostructured Lipid Carrier (NLCs) is a modification of the SLN system, consisting of a certain amount of lipid matrix and liquid lipids. Mixtures of solid lipids and liquid lipids can provide space for drug trapping. The system will remain in solid form by controlling the concentration of the liquid lipids to be added into the formula so that the drug release process can be controlled.

Item Type: Article
Uncontrolled Keywords: Nanostructured Lipid Carriers, Ubiquinone-10, Transdermal Treatment.
Subjects: R Medicine
R Medicine > RS Pharmacy and materia medica
Divisions: 05. Fakultas Farmasi
Fatchur Rochman, MUNSPECIFIED
Isnaeni, IsnaeniUNSPECIFIED
Depositing User: Mr M. Fuad Sofyan
Date Deposited: 10 Sep 2019 01:42
Last Modified: 10 Sep 2019 01:42
Sosial Share:

Actions (login required)

View Item View Item